Paper26416355
Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.
Slabáková E and 12 others. Oncotarget, 2015. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells. Papers, record 26416355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26416355
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Nuclear Proteins | Major topic |
| Prostatic Neoplasms | Major topic |
| Proto-Oncogene Proteins | Major topic |
| Proto-Oncogene Proteins c-mdm2 | Major topic |
| Animals | |
| Cell Cycle Proteins | |
| Cell Line, Tumor | |
| Female | |
| Heterografts | |
| Humans | |
| Male | |
| Mice | |
| Mice, Nude | |
| Phenotype | |
| Transfection |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20689556 | Mutant p53(R175H) upregulates Twist1 expression and promotes epithelial-mesenchymal transition in immortalized prostate cells. | Cell Death Differ | 2011 | https://conductscience.org/library/papers/20689556 | PubMed |
| 2 | 21199805 | Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. | Cancer Res | 2011 | https://conductscience.org/library/papers/21199805 | PubMed |
| 3 | 21386656 | The phenotype of MDM2 auto-degradation after DNA damage is due to epitope masking by phosphorylation. | Cell Cycle | 2011 | https://conductscience.org/library/papers/21386656 | PubMed |
| 4 | 1614537 | Amplification of a gene encoding a p53-associated protein in human sarcomas. | Nature | 1992 | https://conductscience.org/library/papers/1614537 | PubMed |
| 5 | 8242751 | The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. | Cell | 1993 | https://conductscience.org/library/papers/8242751 | PubMed |
| 6 | 8247544 | Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. | Oncogene | 1993 | https://conductscience.org/library/papers/8247544 | PubMed |
| 7 | 7535634 | Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. | In Vitro Cell Dev Biol Anim | 1995 | https://conductscience.org/library/papers/7535634 | PubMed |
| 8 | 10074902 | Analysis of the degradation function of Mdm2. | Cell Growth Differ | 1999 | https://conductscience.org/library/papers/10074902 | PubMed |
| 9 | 10466430 | FASAY: a simple functional assay in yeast for identification of p53 mutation in tumors. | Neoplasma | 1999 | https://conductscience.org/library/papers/10466430 | PubMed |
| 10 | 15720189 | Chemosensitization by antisense oligonucleotides targeting MDM2. | Curr Cancer Drug Targets | 2005 | https://conductscience.org/library/papers/15720189 | PubMed |
| 11 | 16161005 | Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry. | J Pathol | 2005 | https://conductscience.org/library/papers/16161005 | PubMed |
| 12 | 16912176 | Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. | Cancer Res | 2006 | https://conductscience.org/library/papers/16912176 | PubMed |
| 13 | 16980628 | MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. | Mol Cell Biol | 2006 | https://conductscience.org/library/papers/16980628 | PubMed |
| 14 | 21034743 | MDM2 promotes cell motility and invasiveness through a RING-finger independent mechanism. | FEBS Lett | 2010 | https://conductscience.org/library/papers/21034743 | PubMed |
| 15 | 19448627 | p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. | Nat Cell Biol | 2009 | https://conductscience.org/library/papers/19448627 | PubMed |
| 16 | 21518799 | p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. | J Exp Med | 2011 | https://conductscience.org/library/papers/21518799 | PubMed |
| 17 | 21504235 | Diosgenin suppresses hepatocyte growth factor (HGF)-induced epithelial-mesenchymal transition by down-regulation of Mdm2 and vimentin. | J Agric Food Chem | 2011 | https://conductscience.org/library/papers/21504235 | PubMed |
| 18 | 20631921 | Mouse prostate cancer cell lines established from primary and postcastration recurrent tumors. | Horm Cancer | 2010 | https://conductscience.org/library/papers/20631921 | PubMed |
| 19 | 21321977 | TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug. | Prostate | 2011 | https://conductscience.org/library/papers/21321977 | PubMed |
| 20 | 21910853 | Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts. | Mol Cancer | 2011 | https://conductscience.org/library/papers/21910853 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39273281 | Cucurbitacin B Inhibits the Proliferation of WPMY-1 Cells and HPRF Cells via the p53/MDM2 Axis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273281 | PubMed |
| 38203613 | The Antiproliferative and Proapoptotic Effects of Cucurbitacin B on BPH-1 Cells via the p53/MDM2 Axis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38203613 | PubMed |
| 36994412 | HIF1A overexpression predicts the high lymph node metastasis risk and indicates a poor prognosis in papillary thyroid cancer. | Heliyon | 2023 | https://conductscience.org/library/papers/36994412 | PubMed |
| 36966193 | Variability of fluorescence intensity distribution measured by flow cytometry is influenced by cell size and cell cycle progression. | Sci Rep | 2023 | https://conductscience.org/library/papers/36966193 | PubMed |
| 32647280 | TGF-β regulates Sca-1 expression and plasticity of pre-neoplastic mammary epithelial stem cells. | Sci Rep | 2020 | https://conductscience.org/library/papers/32647280 | PubMed |
| 31217907 | Comparing progression molecular mechanisms between lung adenocarcinoma and lung squamous cell carcinoma based on genetic and epigenetic networks: big data mining and genome-wide systems identification. | Oncotarget | 2019 | https://conductscience.org/library/papers/31217907 | PubMed |
| 31106142 | The CXCR4-LASP1-eIF4F Axis Promotes Translation of Oncogenic Proteins in Triple-Negative Breast Cancer Cells. | Front Oncol | 2019 | https://conductscience.org/library/papers/31106142 | PubMed |
| 30952903 | High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells. | Sci Rep | 2019 | https://conductscience.org/library/papers/30952903 | PubMed |
| 30689920 | The long and the short of it: the MDM4 tail so far. | J Mol Cell Biol | 2019 | https://conductscience.org/library/papers/30689920 | PubMed |
| 30642351 | Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells. | Breast Cancer Res | 2019 | https://conductscience.org/library/papers/30642351 | PubMed |
| 30626627 | Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity. | Cancer Res | 2019 | https://conductscience.org/library/papers/30626627 | PubMed |
| 29462126 | Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer. | Br J Cancer | 2018 | https://conductscience.org/library/papers/29462126 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26416355
GET https://conductscience.org/api/papers/v1/26416355/references?page=2